Blockonomi

Oracle Corporation (ORCL) Stock: Rises as AstraZeneca AI Partnership Targets Clinical Trials

Oracle (ORCL) stock rises 1.20% as an AstraZeneca AI collaboration targets faster clinical trial recruitment, healthcare data ...

Oracle joins forces with AstraZeneca to put AI to work in drug research

Oracle Corp. ORCL announced Tuesday a nonbinding agreement with AstraZeneca Plc AZN to explore using artificial intelligence ...
Asianet Newsable on MSN

Oracle, AstraZeneca explore AI to tackle clinical-trial recruitment challenge

Oracle and AstraZeneca plan to explore AI applications to improve clinical-trial recruitment, accelerate evidence generation ...
Independent Journal Review

AstraZeneca and Oracle begin AI project to speed trial recruitment

AstraZeneca and Oracle signed a non-binding AI deal on Oct. 20, 2026; first program with M42 targets uncontrolled ...
Cryptopolitan on MSN

AstraZeneca partners with Oracle to bring AI into clinical trials

Oracle announced that it has signed a non-binding agreement with AstraZeneca to test the potential for AI and real world ...
Fierce Biotech

AstraZeneca taps Oracle to help improve recruitment for clinical trials

Oracle kicked off the year by launching its Oracle Life Sciences AI Data Platform, which it touted as using generative AI, ...

Oracle stock's next big AI opportunity may have nothing to do with data centres

The AstraZeneca collaboration is a credible wedge into recurring, software-like healthcare AI (Cerner upgrades + trial ...
RTTNews

AstraZeneca, Oracle Launch AI Collaboration To Optimise Clinical Trials

AstraZeneca PLC ( AZN) and Oracle Health & Life Sciences ( ORCL) announced on Tuesday the launch of a global Artificial Intelligence (AI) collaboration to improve clinical trial recruitment, earlier ...
Albawaba.com English

Oracle launches recruitment drive for 1,700 new employees across EMEA

Oracle has announced an EMEA-wide recruitment campaign aimed at hiring 1,700 new employees into the company. The new roles within Oracle are a result of continued growth across all lines of business ...